Application of swine bacillus in oxidation resistance
By using the fermentation supernatant or bacterial suspension of Bacillus subtilis YB-X-721 as antioxidant products, the problem of insufficient antioxidant capacity of pigs under antibiotic-free feeding was solved, and the growth performance and resistance of piglets were significantly improved. Oxidation capacity.
Patent Information
- Application Number
- CN202411011591.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-07-26
AI Technical Summary
Under antibiotic-free feeding conditions, pigs are susceptible to pathogenic Enterobacterial disease, resulting in decreased growth performance and reduced production efficiency, and lack of effective green antibiotic alternatives to improve piglets' antioxidant capacity.
Develop a Bacillus subtilis YB-X-721, which is used to improve piglet antioxidant products through its fermentation supernatant, bacterial suspension or cell-free extract as antioxidant products or as animal feed additives. Oxidation capacity.
The Bacillus porcine origin significantly improved the growth performance of piglets, increased the average daily weight gain, reduced the average daily feed intake and diarrhea rate, and significantly improved the piglets' antioxidant ability, which was close to the effect of commercial probiotics.
Smart Images

Figure CN119033027A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microorganisms, and more specifically, relates to application of porcine bacillus in anti-oxidation. Background Art
[0002] Problems such as bacterial resistance, animal food residues and environmental pollution caused by the long-term addition of antibiotics in feed have seriously affected food safety and human health. In 2020, my country has completely banned the use of feed antibiotics in pig farming, ushering in a new era of antibiotic-free feeding in my country. After the ban on the use of antibiotics, common pathogenic enteric bacilli are very likely to infect pigs, causing diseases such as yellow and white diarrhea, edema, gastroenteritis, sepsis, etc., resulting in a decline in pig growth performance, and severe cases can cause pig deaths, thereby reducing the efficiency of pig farming, and such diseases are difficult to prevent and treat with vaccines. Therefore, in order to eliminate the negative impact of antibiotic-free feeding on pig farming, improve pig farming efficiency, and ensure the intestinal health of pigs, it is urgent to develop green and safe alternative products that are equivalent to antibiotics. In this context, probiotics have become one of the best choices for "antibiotic replacement" with their advantages such as non-toxicity, no residue, not easy to develop drug resistance, anti-intestinal infection and immune promotion. Therefore, the development of efficient and green antibiotic substitutes that can improve the antioxidant capacity of piglets is an urgent problem to be solved in the pig farming industry. Summary of the invention
[0003] An object of the present invention is to solve at least the above problems and / or disadvantages and to provide at least the advantages which will be described hereinafter.
[0004] In order to achieve these purposes and other advantages of the present invention, the present invention provides an application of a porcine Bacillus in anti-oxidation, wherein the porcine Bacillus is Bacillus subtilis YB-X-721, which is classified and named Bacillus subtilis, and has been registered and deposited in the General Microbiological Center of China National Microbiological Culture Collection Committee on November 10, 2023, with a deposit number of CGMCC No. 28942.
[0005] Preferably, the porcine-derived Bacillus is used to prepare an antioxidant product.
[0006] Preferably, the antioxidant product contains Bacillus subtilis YB-X-721, Bacillus subtilis YB-X-721 fermentation supernatant, Bacillus subtilis YB-X-721 bacterial suspension or Bacillus subtilis YB-X-721 cell-free extract.
[0007] Preferably, the method for preparing the Bacillus subtilis YB-X-721 fermentation supernatant is: inoculating Bacillus subtilis YB-X-721 at 1-3% (v / v) into LB liquid culture medium, culturing at 37°C for 24h, centrifuging at 8000g for 10min at 4°C, and collecting the supernatant, which is the Bacillus subtilis YB-X-721 fermentation supernatant.
[0008] Preferably, the preparation method of the Bacillus subtilis YB-X-721 bacterial suspension is as follows: Bacillus subtilis YB-X-721 is inoculated into LB liquid culture medium at 1-3% (v / v), cultured at 37°C for 24h, centrifuged at 8000g for 10min, and collected at 4°C. The obtained bacterial cells are washed 2-3 times with sterile water, resuspended in PBS, and the density is adjusted to 1×10 9 CFU / mL, and obtain Bacillus subtilis YB-X-721 bacterial suspension.
[0009] Preferably, the preparation method of the Bacillus subtilis YB-X-721 cell-free extract is: ultrasonically disrupting a Bacillus subtilis YB-X-721 bacterial suspension in an ice bath, centrifuging at 8000g for 10 minutes, and collecting the supernatant to obtain the Bacillus subtilis YB-X-721 cell-free extract.
[0010] Preferably, the specific conditions of the ultrasonic crushing are: power 240-260W, ultrasonication 3-10s, interval 5-15s, total 10min.
[0011] Preferably, the sequence of 16S rDNA of the swine-derived Bacillus is as shown in SEQ ID NO.1.
[0012] Preferably, the antioxidant product is a bacterial agent or an animal feed additive.
[0013] Preferably, the amount of the animal feed additive added is such that the number of viable bacillus from swine in the feed is 0.5×10 7 ~2×10 7 CFU / g.
[0014] Preferably, the method for preparing the fermentation supernatant comprises:
[0015] Step 1, corn protein powder, quercetin and PBS buffer are mixed, placed in a sweep pulse ultrasonic device, ultrasonic treatment parameters are set, sweep pulse ultrasonic treatment is performed, konjac glucomannan is added, and sweep pulse ultrasonic treatment is continued to obtain a nutrient solution, the nutrient solution is added to LB liquid culture medium, stirred evenly, and sterilized at 121° C. for 20 min to obtain a fermentation medium;
[0016] Step 2, inoculating Bacillus subtilis YB-X-721 strain into fermentation medium at 1-3% (v / v), culturing at 37° C. for 24 h, centrifuging at 8000 g for 10 min at 4° C., collecting the supernatant to obtain YB-X-721 fermentation supernatant;
[0017] Step 3, inoculating Bacillus tequilensis YB-2 strain (preservation number: CCTCC No: M 20221531) into the fermentation medium at 1-3% (v / v), culturing at 37°C for 24 hours, centrifuging at 8000g for 10 minutes at 4°C, and collecting the supernatant to obtain YB-2 fermentation supernatant;
[0018] Step 4: Mix the YB-X-721 fermentation supernatant and the YB-2 fermentation supernatant in a volume ratio of 2 to 5:1 to obtain a composite fermentation supernatant.
[0019] Preferably, the mass volume ratio of the corn protein powder, quercetin, konjac glucomannan and PBS buffer is 5-15g:1-3g:0.5-2g:50-300mL; and the nutrient solution is added to the LB liquid culture medium at 10-30% (v / v).
[0020] Preferably, the swept frequency pulse ultrasonic treatment parameters are: temperature 15-30°C, ultrasonic power 400-800W, frequency 22-40kHz, swept frequency width ±0.5-±2kHz, swept frequency period 100-500ms, pulse ultrasonic time 100-300s, intermittent time 5-15s, and treatment time 5-30min.
[0021] The present invention at least includes the following beneficial effects: the fermentation supernatant, bacterial suspension and cell-free extract of the porcine bacillus subtilis YB-X-721 of the present invention all have certain DPPH free radical, superoxide anion free radical, hydroxyl free radical scavenging ability and certain reducing ability, and can be used to prepare antioxidant products; and the porcine bacillus subtilis YB-X-721 of the present invention is added to piglet feed as an animal feed additive to improve the growth performance of weaned piglets, significantly increase the average daily weight gain, and significantly reduce the average daily feed intake, feed-to-weight ratio and diarrhea rate.
[0022] Other advantages, objectives and features of the present invention will be embodied in part through the following description, and in part will be understood by those skilled in the art through study and practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The diagram is a comparison of the inhibition zones of the porcine Bacillus sp. YB-M-32, YB-M-123, YB-X-416 and YB-X-721 of the present invention, wherein: A is Escherichia coli; B is Salmonella; C is Staphylococcus aureus;
[0024] Figure 2 The Gram staining diagram of the porcine Bacillus YB-X-721 of the present invention;
[0025] Figure 3 This is a spore staining diagram of the porcine Bacillus YB-X-721 of the present invention;
[0026] Figure 4 This is a colony morphology diagram of the porcine-derived Bacillus YB-X-721 of the present invention;
[0027] Figure 5 The genetic evolution tree of the porcine Bacillus YB-X-721 of the present invention;
[0028] Figure 6 This is the growth curve of the porcine Bacillus YB-X-721 of the present invention. DETAILED DESCRIPTION
[0029] The present invention is further described in detail below in conjunction with the accompanying drawings so that those skilled in the art can implement the invention with reference to the description.
[0030] It should be understood that the terms such as “having”, “including” and “comprising” used herein do not exclude the existence or addition of one or more other elements or combinations thereof.
[0031] Example 1
[0032] An application of a porcine bacillus in anti-oxidation, wherein the porcine bacillus is Bacillus subtilis YB-X-721, which is classified as Bacillus subtilis, and has been registered and deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration on November 10, 2023, with a deposit number of CGMCC No. 28942;
[0033] Screening and Isolation of Swine-derived Bacillus:
[0034] Fresh feces of healthy adult Rongchang pigs raised without antibiotics were used as samples. An appropriate amount of feces sample was weighed aseptically, placed in PBS buffer, shaken to mix thoroughly, and placed in a 90°C water bath for 10 min to kill other non-spore-forming bacteria. Then, it was diluted gradiently with sterile water, and an appropriate amount of the dilution was spread on soybean casein agar (TSA) medium, placed in a 37°C incubator, and inverted for incubation for 48 h. The growth of the plate colony was observed, and a single colony was streaked and inoculated on a new plate for purification and culture. Finally, four strains of Bacillus were screened and isolated, numbered YB-M-32, YB-M-123, YB-X-416 and YB-X-721.
[0035] Screening of the antagonistic pathogenic bacteria characteristics of swine-derived Bacillus:
[0036] In order to further obtain Bacillus with good antibacterial effect, the candidate bacteria were tested for inhibiting pathogens: the LB solid medium was sterilized and cooled to about 50°C, then poured into a sterile culture dish. After the plate was naturally dried, 0.1 mL of indicator bacteria solution (10 8 CFU / mL) was evenly spread on the plate, and after natural drying, a hole was punched on the plate, and 0.1 mL of the test bacterial solution was added to the hole. After the bacterial solution penetrated into the plate, it was cultured at 37°C for 24 hours, and the size of the inhibition zone was measured. Among them, the indicator bacteria were Escherichia coli, Staphylococcus aureus and Salmonella. The inhibition results are shown in Table 1, and the comparison of the inhibition zones is shown in the figure below. Figure 1 As shown (A Escherichia coli; B Salmonella; C Staphylococcus aureus).
[0037] Table 1
[0038]
[0039] A Bacillus strain YB-X-721 was screened out and was able to inhibit Escherichia coli, Staphylococcus aureus and Salmonella. Morphological identification, physiological and biochemical characteristics identification and molecular biological identification were carried out.
[0040] Morphological identification of Bacillus subtilis YB-X-721 from pigs:
[0041] In a sterile operating table, the purified Bacillus isolates were streaked on LB plates and cultured at 37°C for 24 hours. The size, shape, gloss, color, transparency and other characteristics of the single colonies were observed and recorded. The isolates were subjected to Gram staining ( Figure 2 ) and spore staining ( Figure 3 ), the staining steps refer to the staining kit, and the bacterial morphology is observed and recorded under a microscope; the colony morphology of the swine Bacillus subtilis YB-X-721 strain is shown in Table 2 and Figure 4 .
[0042] Table 2
[0043] Colony color Size(mm) form edge Raised transparent texture YB-X-721 White 3.5 Round irregular no no Not smooth
[0044] Acid and bile resistance test of Bacillus subtilis YB-X-721 from pigs:
[0045] Bile salt tolerance test:
[0046] The strain was inoculated into LB liquid culture medium. After culturing for 24 h, the bacterial solution was inoculated into LB liquid culture medium with different bile salt levels (0.15% and 0.3%) at a ratio of 5% (v / v) and placed at 37°C for 4 h. 100 μL of the bacterial solution was diluted 10-fold at 0 and 4 h, and 10 -5 The gradient dilutions were spread on LB plates, cultured at 37°C for 24 h, and the colonies were counted. Each sample was replicated three times.
[0047] Survival rate (%) = "4h" colony count / "0h" colony count × 100%
[0048] Acid resistance test:
[0049] The strain was inoculated into LB liquid culture medium. After culturing for 24 h, the bacterial solution was inoculated into LB liquid culture medium with pH 2 and 3 at a ratio of 5% (v / v) and placed at 37°C for 4 h. 100 μL of the bacterial solution was diluted 10-fold at 0 and 4 h, and 10 -5 The gradient dilutions were spread on LB plates, cultured at 37°C for 24 h, and the colonies were counted. Each sample was replicated three times.
[0050] Survival rate (%) = "4h" colony count / "0h" colony count × 100%
[0051] The test results are shown in Table 3, which shows that the porcine Bacillus subtilis YB-X-721 has excellent acid and bile salt resistance.
[0052] Table 3
[0053]
[0054] Identification of physiological and biochemical characteristics of Bacillus subtilis YB-X-721 from pigs:
[0055] The physiological and biochemical characteristics of strain YB-X-721 were tested according to the steps in the biochemical detection kit, and the results are shown in Table 4. A comparative analysis was performed with reference to the "Common Bacterial System Identification Manual" and the "Berger's Bacterial Identification Manual", and it was preliminarily determined to be a Bacillus bacterium.
[0056] Table 4
[0057] project result project result Catalase + Sorbitol - VP reaction - Aesculin - Methyl red reaction - glucose - Starch hydrolysis - Raffinose - Cellobiose - sucrose - maltose - gelatin + Mannitol -
[0058] In the table, + indicates positive; - indicates negative.
[0059] Molecular biological identification of Bacillus subtilis YB-X-721 from pigs:
[0060] PCR amplification was performed using the bacterial identification 16S rDNA universal primers 27F and 1492R. The primer sequences are shown in Table 5. The primers were synthesized by Shanghai Shenggong Biotechnology Co., Ltd.;
[0061] Table 5
[0062]
[0063] The PCR amplification template was fresh bacterial solution after activation, the system was 50 μL, and the reaction system was shown in Table 6;
[0064] Table 6
[0065]
[0066]
[0067] The PCR amplification program was as follows: 95℃5min; 95℃45s; 55℃45s; 72℃1min; repeated 35 cycles; 72℃8min. The PCR amplification products were identified by 1% agarose gel electrophoresis and sequenced at Shanghai Sangon Biotechnology Co., Ltd., and BLAST comparison analysis was performed in GenBank.
[0068] Perform BLAST comparison in GenBank and draw a genetic evolution tree, such as Figure 5 The results showed that YB-X-721 and the reference strain Bacillus subtilis (NCIB 3610) were on the same branch and had a very high affinity, so it was determined that YB-X-721 was Bacillus subtilis and named Bacillus subtilis YB-X-721; the 16S rDNA sequence of the porcine Bacillus subtilis YB-X-721 obtained by sequencing was shown in SEQ ID NO.1.
[0069] Analysis of biological characteristics of Bacillus subtilis YB-X-721 from pigs:
[0070] After the strain was activated for one generation, it was inoculated into 100 mL LB liquid medium at a 2% (v / v) inoculation volume and cultured at 37°C with shaking. 5 mL of the bacterial solution was taken every 4 hours for testing. The concentration (OD value) of the bacterial solution was measured at a wavelength of 600 nm using an ultraviolet spectrophotometer for a total of 24 hours. Figure 6 ), it can be found that YB-X-721 entered the logarithmic growth phase after 2 hours and entered the stable phase after 10 hours.
[0071] Example 2
[0072] Application of a pig-derived bacillus in anti-oxidation
[0073] In vitro antioxidant activity of the porcine-derived Bacillus of the present invention:
[0074] 1. Preparation of bacterial solution and in vitro antioxidant assay
[0075] 1. Reagents
[0076] Anhydrous ethanol, potassium ferricyanide, PBS buffer, acetic acid, ferric chloride, ascorbic acid, hydrogen peroxide, ferrous sulfate, 3,5-dinitrosalicylic acid (DNS), pyrogallol, tris(hydroxymethylaminomethane)-hydrochloric acid buffer solution (Tris), phosphate buffer, o-phenanthroline solution, etc., all of the above reagents were of analytical grade.
[0077] 2. Extraction of sample bacterial solution
[0078] The different components of the strain were prepared according to the method of Gao Li'e (Gao Li'e. Study on the Diversity and Antioxidant Properties of Lactic Acid Bacteria in Traditional Fermented Yak Milk on the Qinghai-Tibet Plateau [D]. Lanzhou University, 2020. DOI: 10.27204 / d.cnki.glzhu.2020.002996.). The strain was inoculated into LB liquid medium at 2% (v / v), cultured at 37°C for 24h, centrifuged at 8000g for 10min, and the supernatant and bacteria were collected separately at 4°C. The supernatant was the fermentation supernatant (FS). The obtained bacteria were washed 2 to 3 times with sterile water, resuspended in PBS, and the density was adjusted to 1×10 9 CFU / mL, and it was equally divided into two parts, one part was used as bacterial suspension (IC), and the other part was ultrasonically disrupted in an ice bath (250 W, ultrasonic for 5 s, interval of 10 s, total 10 min), centrifuged at 8000 g for 10 min, and the supernatant was collected to obtain the cell-free extract (CFE).
[0079] 3. In vitro antioxidant activity assay
[0080] 3.1 Determination of DPPH free radical scavenging ability
[0081] Take 1 mL of the sample and place it in a test tube. Add 2 mL of DPPH anhydrous ethanol solution (concentration is 0.2 mmol / L). After mixing, react at room temperature in the dark for 30 min. Centrifuge at 8000 g for 10 min at 4°C, take the supernatant, measure its absorbance at 517 nm, adjust to zero with deionized water, repeat 3 times for each group, and calculate the average value.
[0082] DPPH removal rate (%) = [1-(A sample-A blank) / A control] × 100%
[0083] (Blank group: DPPH was replaced by an equal volume of anhydrous ethanol; control group: the sample solution was replaced by an equal volume of distilled water, and the blank was adjusted to zero with an equal volume of a mixture of distilled water and anhydrous ethanol)
[0084] Liquid preparation: 0.2mmol / L DPPH anhydrous ethanol solution: weigh 50mg DPPH, add 634mL anhydrous ethanol, and shake well.
[0085] 3.2 Determination of hydroxyl radical (·OH) scavenging activity (Fenton method)
[0086] The Fenton method uses H2O2 and Fe 2+ The mixture undergoes a Fenton reaction, generating ·OH with high reactivity, and salicylic acid can capture ·OH and produce a colored substance (dihydroxybenzoic acid), which has a maximum absorption at 510nm. However, if a certain amount of a substance with scavenging ability is added, it will compete with the reaction of salicylic acid, resulting in a decrease in the amount of colored substance (dihydroxybenzoic acid) produced, causing a certain change in the absorbance of the solution. The activity of the antioxidant can then be measured based on the change in absorbance.
[0087] H2O2+Fe 2+ → OH+OH - +Fe 3+
[0088] Liquid preparation: ①FeSO4 solution: accurately weigh 0.05g of ferrous sulfate heptahydrate and place it in a 100mL volumetric flask, add distilled water to the mark, and shake well to obtain a 1.8mmol / L ferrous sulfate solution;
[0089] ② Salicylic acid-ethanol solution: accurately weigh 0.0249 g of salicylic acid and place it in a 100 mL volumetric flask, add anhydrous ethanol to the mark, shake well and stabilize to obtain a 1.8 mmol / L salicylic acid-ethanol solution;
[0090] ③0.3% H2O2 solution: Accurately measure 1.0mL of 30% hydrogen peroxide and place it in a 100mL volumetric flask, add distilled water to the scale, and mix well to obtain 0.3% H2O2 solution.
[0091] The specific steps are as follows: add 2mL of 1.8mmoL / L FeSO4 solution, 1mL of sample, and 0.1mL of 0.3% H2O2 solution to the test tube in turn, shake well, then add 1.5mL of 1.8mmol / L salicylic acid-ethanol solution, shake well, let stand at 30℃ for 30min, and measure the sample group absorbance Ai at 510nm; replace the H2O2 solution in the sample group with an equal amount of distilled water, react, and use it as the sample reference group and measure its absorbance Aj; replace the sample in the sample group with an equal amount of distilled water, react, and use it as the blank control group to measure the absorbance Ao. Calculate the hydroxyl radical scavenging rate according to the following formula:
[0092] Hydroxyl free radical scavenging rate (%) = [Ao-(Ai-Aj) / Ao] × 100%
[0093] 3.3 Superoxide anion free radical (O2 - ·) Determination of scavenging activity (pyrogallol method)
[0094] Pyrogallol is very easy to self-oxidize in an alkaline environment, producing colored intermediates and superoxide anions O2 - ·, O2 - It also catalyzes the self-oxidation reaction, and the amount of O2 can be determined based on the amount of colored substances produced. - When adding substances with antioxidant activity, the self-oxidation of pyrogallol can be weakened, so that the antioxidant activity can be judged by the trend of reducing colored substances.
[0095] Liquid preparation: ① Pyrogallol: Accurately weigh 0.315g of pyrogallol and place it in a 100mL volumetric flask, then add 10mL of 0.1mol / L hydrochloric acid, and finally add distilled water to the scale, shake well, and you will get 25mmol / L of pyrogallol; pyrogallol should be prepared and used immediately, and react at 20℃;
[0096] ②Tris-HCl: Accurately weigh 3.0285g of Tris reagent and place it in a 500mL volumetric flask. Then add 114.5mL of 0.1mol / L hydrochloric acid. Finally, add distilled water to the scale and shake well to obtain 0.05mol / L Tris-HCl buffer.
[0097] The specific steps are as follows: take out the test tube and add 7.5mL 0.05mol / L Tris-HCl buffer solution, place it in a 25℃ water bath to preheat for 20min, then add 1mL sample solution and 0.5mL 25mmol / L pyrogallol solution respectively, mix them and place them in a 25℃ water bath to react for 5min, add 1mL concentrated HCl to terminate the reaction, and use the sample group to measure the absorbance Ai of the solution at 320nm wavelength under a UV-visible spectrophotometer; the sample reference group uses the same volume of distilled water to replace the pyrogallol solution and measure the absorbance Aj of the solution; the blank control group uses the same volume of distilled water to replace the sample solution and measure the absorbance Ao of the solution. Calculate O2 according to the following formula - Clearance rate:
[0098] Superoxide anion free radical scavenging rate (%) = [Ao-(Ai-Aj)] / Ao×100%
[0099] 3.4 Determination of reducing capacity
[0100] Liquid preparation: ① 0.2 mol / L, pH 6.6 phosphate buffer solution: first prepare 0.2M Na2HPO4 (17.19 g Na2HPO4·12H2O+240 mL H2O) and 0.2M NaH2PO4 (11.23 g NaH2PO4·2H2O+360 mL H2O) of solution A and solution B, respectively; take 40 mL of solution A and 60 mL of solution B, and mix them to obtain a 0.2 mol / L, pH 6.6 phosphate buffer solution;
[0101] ②1% potassium ferrocyanide: 1g potassium ferrocyanide + 100mL H2O;
[0102] ③10% trichloroacetic acid: 1 mL trichloroacetic acid + 9 mL H2O;
[0103] ④0.1% ferric chloride: 0.1g ferric chloride + 100mL H2O.
[0104] Take 0.5mL of sample and place it in a test tube, add 0.5mL of phosphate buffer solution with a concentration of 0.2mol / L and pH 6.6, then add 0.5mL of 1% potassium ferricyanide, place in a 50℃ water bath for 20min, then quickly cool in an ice bath, then add 0.5mL of 10% trichloroacetic acid, centrifuge at 4000r / min for 10min, take 1mL of supernatant, add 1mL of distilled water and 1mL of 0.1% ferric chloride, mix well, place at room temperature for 10min, measure its absorbance at a wavelength of 700nm, repeat 3 times for each sample, and calculate the average value. The larger the absorbance, the stronger the reducing ability of the sample to be tested.
[0105] The results are shown in Table 7. The fermentation supernatant (FS), bacterial suspension (IC) and cell-free extract (CFE) of the porcine Bacillus subtilis YB-X-721 of the present invention all have certain DPPH free radical, superoxide anion free radical, hydroxyl free radical scavenging ability and certain reducing ability, indicating that the strain has certain antioxidant activity in vitro.
[0106] Table 7
[0107]
[0108] Example 3
[0109] An application of porcine bacillus in anti-oxidation includes:
[0110] Step 1, corn protein powder, quercetin and PBS buffer are mixed, placed in a sweep pulse ultrasonic device, ultrasonic treatment parameters are set, sweep pulse ultrasonic treatment is performed for 10 min, konjac glucomannan is added, and sweep pulse ultrasonic treatment is continued for 10 min to obtain nutrient solution, the nutrient solution is added to LB liquid culture medium at 15% (v / v), stirred, and sterilized at 121°C for 20 min to obtain fermentation medium; wherein, the mass volume ratio of corn protein powder, quercetin, konjac glucomannan and PBS buffer is 8g:2g:1g:100mL; sweep pulse ultrasonic treatment parameters are: temperature 25°C, ultrasonic power 600W, frequency 28kHz, sweep width ±2kHz, sweep period 300ms, pulse ultrasonic time 200s, and interval 10s;
[0111] Step 2: Bacillus subtilis YB-X-721 strain was inoculated into fermentation medium at 2% (v / v), cultured at 37° C. for 24 h, centrifuged at 8000 g for 10 min at 4° C., and the supernatant was collected to obtain YB-X-721 fermentation supernatant.
[0112] In this embodiment, when culturing the strain, the prepared nutrient solution is added to the LB liquid culture medium, and the obtained fermentation medium is more conducive to the growth and metabolism of porcine Bacillus, promotes the strain to secrete metabolites with good antioxidant capacity, and improves the antioxidant capacity of the fermentation supernatant; wherein, when preparing the nutrient solution, it is subjected to swept-frequency pulse ultrasound treatment, and the synergistic effect of pulse ultrasound and swept-frequency ultrasound is utilized to improve the mixing efficiency and the uniformity and dispersion of various substances in the nutrient solution, so that the contact between the strain and various substances is more sufficient.
[0113] Example 4
[0114] An application of porcine bacillus in anti-oxidation includes:
[0115] Step 1, corn protein powder, quercetin and PBS buffer are mixed, pulsed ultrasonic treatment is performed for 10 minutes, konjac glucomannan is added, and pulsed ultrasonic treatment is continued for 10 minutes to obtain a nutrient solution, and the nutrient solution is added to LB liquid culture medium at 15% (v / v), stirred evenly, and sterilized at 121° C. and autoclaved for 20 minutes to obtain a fermentation medium; wherein the mass volume ratio of corn protein powder, quercetin, konjac glucomannan and PBS buffer is 8g:2g:1g:100mL; the pulsed ultrasonic treatment parameters are: temperature 25° C., ultrasonic power 600W, frequency 28kHz, pulsed ultrasonic time 200s, and interval 10s;
[0116] Step 2: Bacillus subtilis YB-X-721 strain was inoculated into fermentation medium at 2% (v / v), cultured at 37° C. for 24 h, centrifuged at 8000 g for 10 min at 4° C., and the supernatant was collected to obtain YB-X-721 fermentation supernatant.
[0117] Example 5
[0118] An application of porcine bacillus in anti-oxidation includes:
[0119] Step 1, corn protein powder and PBS buffer are mixed, placed in a sweep pulse ultrasonic device, ultrasonic treatment parameters are set, sweep pulse ultrasonic treatment is carried out for 10 min, konjac glucomannan is added, and sweep pulse ultrasonic treatment is continued for 10 min to obtain nutrient solution, the nutrient solution is added to LB liquid culture medium at 15% (v / v), stirred, and sterilized at 121°C for 20 min to obtain fermentation medium; wherein, the mass volume ratio of corn protein powder, konjac glucomannan and PBS buffer is 8g:1g:100mL; sweep pulse ultrasonic treatment parameters are: temperature 25°C, ultrasonic power 600W, frequency 28kHz, sweep width ±2kHz, sweep period 300ms, pulse ultrasonic time 200s, and interval 10s;
[0120] Step 2: Bacillus subtilis YB-X-721 strain was inoculated into fermentation medium at 2% (v / v), cultured at 37° C. for 24 h, centrifuged at 8000 g for 10 min at 4° C., and the supernatant was collected to obtain YB-X-721 fermentation supernatant.
[0121] Example 6
[0122] An application of porcine bacillus in anti-oxidation includes:
[0123] Step 1, corn protein powder, quercetin and PBS buffer are mixed, placed in a sweep pulse ultrasonic device, ultrasonic treatment parameters are set, sweep pulse ultrasonic treatment is performed for 10 min, konjac glucomannan is added, and sweep pulse ultrasonic treatment is continued for 10 min to obtain nutrient solution, the nutrient solution is added to LB liquid culture medium at 15% (v / v), stirred, and sterilized at 121°C for 20 min to obtain fermentation medium; wherein, the mass volume ratio of corn protein powder, quercetin, konjac glucomannan and PBS buffer is 8g:2g:1g:100mL; sweep pulse ultrasonic treatment parameters are: temperature 25°C, ultrasonic power 600W, frequency 28kHz, sweep width ±2kHz, sweep period 300ms, pulse ultrasonic time 200s, and interval 10s;
[0124] Step 2, inoculating Bacillus subtilis YB-X-721 strain into fermentation medium at 2% (v / v), culturing at 37°C for 24h, centrifuging at 8000g for 10min at 4°C, collecting the supernatant to obtain YB-X-721 fermentation supernatant;
[0125] Step 3, Bacillus tequilensis YB-2 strain (preservation number: CCTCC No: M 20221531) was inoculated into the fermentation medium at 2% (v / v), cultured at 37°C for 24h, centrifuged at 8000g for 10min at 4°C, and the supernatant was collected to obtain YB-2 fermentation supernatant;
[0126] Step 4: Mix the YB-X-721 fermentation supernatant and the YB-2 fermentation supernatant in a volume ratio of 3:1 to obtain a composite fermentation supernatant.
[0127] In this embodiment, the YB-X-721 fermentation supernatant and the YB-2 fermentation supernatant are compounded to prepare a composite fermentation supernatant, and the antioxidant capacity is further improved.
[0128] The in vitro antioxidant activity of the fermentation supernatants prepared in Examples 3 to 5 and the composite fermentation supernatant prepared in Example 6 was measured, and the results are shown in Table 8. It can be seen that compared with the fermentation supernatant in Example 2, the antioxidant capacity of Examples 3 to 6 is higher than that of Example 2, and the composite fermentation supernatant of Example 6 has the best antioxidant capacity.
[0129] Table 8
[0130]
[0131] Example 7
[0132] Application of a pig-derived bacillus in anti-oxidation
[0133] Antioxidant activity of the porcine Bacillus subtilis YB-X-721 in animals:
[0134] 1. Preparation of probiotic solution
[0135] The strain was inoculated into LB solid medium and activated for three generations. A 20L automatic fermenter was used to prepare the probiotic solution. The plate count method was used to calculate the number of live bacteria in the produced solution. The number of live bacteria of Bacillus subtilis YB-X-721 from pigs in the sample was 1×10 10 CFU / g.
[0136] 2. Animal Experimentation
[0137] Eighteen healthy Rongchang piglets, 28 days old and weaned with an average weight of 6.9-7.1 kg, were selected. Based on the principle of similar weight and consistent ratio of male and female piglets, the experimental piglets were randomly divided into three groups, with one pen in each group and six piglets in each pen, half male and half female. The control group was fed a basic diet, and the YB-X-721 group added YB-X-721 probiotic solution to the basic diet to adjust the number of live bacteria in the feed to 1×10 7 CFU / g, the commercial probiotic group added Yishengkang synthetic microbial preparation (Guangdong Broad Science and Technology) to the basal diet to adjust the number of viable bacteria in the feed to 1×10 7 CFU / g, pre-feeding period of 3 days, formal test period of 28 days. The test pigs were fed and managed according to the routine pig farm, and the immunization, deworming and disinfection procedures during the test were carried out according to the normal procedures of the pig farm. At the end of the test feeding, 5mL of blood was collected from the anterior vena cava of each group, placed in a serum tube for coagulation, centrifuged at 3000r / min for 10min, and the serum was separated and stored at -20℃ for testing.
[0138] 3. Growth performance
[0139] On the morning of the first and 28th day of the experiment, the piglets were weighed on an empty stomach, and the feed intake was recorded and diarrhea was observed every day during the experiment. The average daily feed intake, average daily weight gain and feed-to-weight ratio for 28 days were calculated based on the feed intake and weight gain.
[0140] Diarrhea rate (%) = total number of diarrhea episodes / (total number of experimental pigs × total number of experimental days) × 100%
[0141] 4. Determination of antioxidant capacity
[0142] The collected piglet serum samples were tested using an antioxidant capacity index detection kit, and a total of five indicators were measured: total antioxidant capacity (T-AOC), total superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-PX), and malondialdehyde (MDA).
[0143] The growth performance test results of weaned piglets are shown in Table 8. Compared with the control group, the birth weight and the weight on the 28th day of the experiment of the YB-X-721 group had no significant difference (P>0.05), the average daily weight gain was significantly increased, and the average daily feed intake, feed-to-weight ratio and diarrhea rate were significantly reduced, indicating that the addition of YB-X-721 to the feed improves the growth performance of weaned piglets. In addition, the effect of the porcine Bacillus subtilis YB-X-721 of the present invention on the growth performance of piglets is close to that of commercial probiotics.
[0144] Table 8
[0145]
[0146] In the table, data in the same row with different letters on their shoulders indicate significant differences (P < 0.05); data with the same letters on their shoulders or no letters on their shoulders indicate no significant differences (P > 0.05).
[0147] The results of the antioxidant capacity determination are shown in Table 9. The activities of T-SOD, GSH-PX and T-AOC in the serum of piglets in the YB-X-721 group were significantly higher than those in the control group (P<0.05), while the MDA content was lower than that in the control group. This indicates that YB-X-721 improves the antioxidant capacity of weaned piglets. In addition, the effect of the porcine Bacillus subtilis YB-X-721 on improving the antioxidant capacity of piglets is close to that of commercial probiotics.
[0148] Table 9
[0149]
[0150] In the table, data in the same row with different letters on their shoulders indicate significant differences (P < 0.05); data with the same letters on their shoulders or no letters on their shoulders indicate no significant differences (P > 0.05).
[0151] Although the embodiments of the present invention have been disclosed as above, they are not limited to the applications listed in the specification and the implementation modes, and they can be fully applied to various fields suitable for the present invention. For those familiar with the art, additional modifications can be easily implemented. Therefore, without departing from the general concept defined by the claims and the scope of equivalents, the present invention is not limited to the specific details and the illustrations shown and described herein.
Claims
1. An application of porcine Bacillus in anti-oxidation, characterized in that: The porcine-derived Bacillus is used to prepare an antioxidant product; The porcine-derived Bacillus is Bacillus subtilis YB-X-721, and its classification name is Bacillus subtilis. It was registered and preserved in the General Microbiology Center of China National Microbiological Culture Collection on November 10, 2023, with the preservation number CGMCC No.28942.
2. The use of a porcine bacillus in anti-oxidation as claimed in claim 1, characterized in that: The antioxidant product contains Bacillus subtilis YB-X-721, Bacillus subtilis YB-X-721 fermentation supernatant, Bacillus subtilis YB-X-721 bacterial suspension or Bacillus subtilis YB-X-721 cell-free extract.
3. The use of a porcine bacillus in anti-oxidation as claimed in claim 2, characterized in that: The preparation method of the Bacillus subtilis YB-X-721 fermentation supernatant is as follows: Bacillus subtilis YB-X-721 is inoculated into LB liquid culture medium at 1-3% (v / v), cultured at 37°C for 24 hours, centrifuged at 8000g for 10 minutes at 4°C, and the supernatant is collected to obtain the Bacillus subtilis YB-X-721 fermentation supernatant.
4. The use of a porcine bacillus in anti-oxidation as claimed in claim 2, characterized in that: The preparation method of the Bacillus subtilis YB-X-721 bacterial suspension is as follows: Bacillus subtilis YB-X-721 is inoculated into LB liquid culture medium at 1-3% (v / v), cultured at 37°C for 24 hours, centrifuged at 8000g for 10 minutes, and collected bacterial cells at 4°C. The obtained bacterial cells are washed 2-3 times with sterile water and resuspended in PBS to obtain the Bacillus subtilis YB-X-721 bacterial suspension.
5. The use of a porcine bacillus in anti-oxidation as claimed in claim 4, characterized in that: In the Bacillus subtilis YB-X-721 bacterial suspension, the concentration of Bacillus subtilis YB-X-721 is 0.5×10 9 ~2×10 9 CFU / mL.
6. The use of a porcine bacillus in anti-oxidation as claimed in claim 2, characterized in that: The preparation method of the Bacillus subtilis YB-X-721 cell-free extract comprises: ultrasonically disrupting a Bacillus subtilis YB-X-721 bacterial suspension under ice bath conditions, centrifuging at 8000g for 10 minutes, and collecting the supernatant to obtain the Bacillus subtilis YB-X-721 cell-free extract.
7. The use of a porcine bacillus in anti-oxidation as claimed in claim 6, characterized in that: The specific conditions of the ultrasonic crushing are: power 240-260W, ultrasonication 3-10s, interval 5-15s, a total of 10 minutes.
8. The use of the porcine bacillus in anti-oxidation as claimed in claim 1, characterized in that: The sequence of the 16S rDNA of the swine-derived Bacillus is shown as SEQ ID NO.
1.
9. The use of the porcine bacillus in anti-oxidation as claimed in claim 1, characterized in that: The antioxidant product is a bacterial agent or an animal feed additive.
10. The use of the porcine bacillus in anti-oxidation as claimed in claim 9, characterized in that: The amount of the animal feed additive added is such that the number of live bacteria of the swine-derived Bacillus in the feed is 0.5×10 7 ~2×10 7 CFU / g.
Citation Information
Patent Citations
Min pig source bacillus subtilis wet fermentation nursing piglet concentrated feed as well as preparation method and application thereof
CN115624103A
Application of swine bacillus in preparation of antioxidant and immunity-improving product
CN115918909A
Application of lactobacillus salivarius in oxidation resistance
CN116103208A
Swine bacillus and application thereof
CN116496929A
Bacillus subtilis strain with probiotic activity
US20200113952A1
